Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine	Bacterial Infections and Mycoses, Infections, Pasteurellaceae Infections, bacterial infectious disease, gram-negative bacterial infections, haemophilus infectious disease	Active, not recruiting	Phase 2	2026-08-03		NCT07743008

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Center for Vaccinology	6
Canadian Immunization Research Network	6
Dalhousie University	49
InventVacc Biologicals Inc.	2
McGill University Health Centre/Research Institute of the McGill University Health Centre	139

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Canadian Center for Vaccinology	Halifax	Canada	4
Vaccine Study Centre of the McGill University Health Centre	Montreal	Canada	1